Pregnancy‐specific glycoprotein 9 acts as both a transcriptional target and a regulator of the canonical TGF‐β/Smad signaling to drive breast cancer progression
Yingying Liu(Shanghai Medical College of Fudan University), Da‐Qiang Li(Shanghai Medical College of Fudan University)
Cited by 13
Related Papers
Acetylation of MORC2 by NAT10 regulates cell-cycle checkpoint control and resistance to DNA-damaging chemotherapy and radiotherapy in breast cancer
|Nucleic Acids Research|2020|228
O-GlcNAcylation of MORC2 at threonine 556 by OGT couples TGF-β signaling to breast cancer progression
|Cell Death and Differentiation|2022|97
USP9X stabilizes BRCA1 and confers resistance to DNA‐damaging agents in human cancer cells
|Cancer Medicine|2019|49
Requirement of MTA1 in ATR-mediated DNA Damage Checkpoint Function
|Journal of Biological Chemistry|2010|41